Asia-Pacific Pharmaceuticals increased its capital to 740 million yuan.

According to the Enterprise Check APP, recently, there has been a business change in Asia-Pacific Pharmaceutical Industry, with its registered capital increasing from 600 million yuan to 740 million yuan. Information from Enterprise Check shows that the company was established in December 2001, with Cen Jianwei as the legal representative. Its business scope includes drug production, drug import and export, and drug Internet information services. The company is jointly held by Ningbo Fubon Holdings Group Co., Ltd., Zhejiang Asia-Pacific Group Co., Ltd., among others.